NSEAppointment7 Sept 2026 · 7 Sept 2026, 03:13 pm

Appointment

Alpa Laboratories Limited · ALPA

✦ AI SummaryMgmt Change

Alpa Laboratories Limited has informed the Exchange regarding the appointment of Mrs. Radhika Biyani as a Non-Executive Director of the company, effective September 05, 2026. The appointment is subject to the approval of the members of the Company at the ensuing General Meeting or by way of postal ballot.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alpa Laboratories Limited has informed the Exchange regarding Appointment of Mrs RADHIKA as Non- Execut of the company w.e.f. September 05, 2026.

Attachments (1)

📄

ALPA_07092026150738_DISCLOSURE_of_Radhika.pdf

pdf

Download →
View document text
Alpa Laboratories Ltd. 332, AB. Road, Pigdamber 453 446, Dist.- Indore (M.P.) 452 001 Email : mkigdom@alpalabs.in Email : hr@alpalabs.in Date: - 05™ September, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited. Bombay Stock Exchange Limited. ‘Exchange Plaza’, C-1, Block G, Rotunda Building, P J Towers, Bandra - Kurla Complex, Dalal Street, Fort, Bandra (E), Mumbai - 400 051 Mumbai - 400 001 Scrip Code: ALPA Scrip Code: 532878 Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 read with Para A of Part A of Schedule 111 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), and further to our earlier intimation regarding the cessation of Mrs. Jyoti Jain as an Independent Director of the Company with effect from 21st July 2026 on completion of her tenure, we wish to inform you that the Board of Directors of the Company, at its meeting held on 13th August 2026, approved the appointment of Mrs. Radhika Biyani as an Additional Director in the Independent, Non-Executive category, subject to allotment of a valid Director Identification Number (DIN) to her in terms of Sections 152 and 154 of the Companies Act, 2013, with the appointment to take effect from the date of such allotment. DIN 11918173 was subsequently allotted to Mrs. Biyani, and her appointment accordingly took the effect. The appointment is subject to the approval of the members of the Company at the ensuing General Meeting, or by way of postal ballot, within the timeline prescribed under Regulation 17 of the SEBI Listing Regulations. The requisite details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule 111 thereof and SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 are enclosed herewith as Annexure-A. We wish to place on record that there was an intervening period between the cessation of Mrs. Jyoti Jain's tenure on 21st July 2026 and the appointment of Mrs. Radhika Biyani taking effect on 5th September 2026. This intervening period was on account of the time required to complete the search and evaluation process for identifying a suitable candidate possessing the requisite skills, experience and independence, the time taken to complete due diligence and eligibility verification, and thereafter the time taken for allotment of DIN to the proposed appointee, in accordance with the requirements of the Companies Act, 2013 and the SEBI Listing Regulations. The Company has since taken steps to strengthen its internal tracking ofd irector tenure timelines and DIN-related processes so as to avoid any recurrence of such delays in the future. E.ln Alpa Laboratories Ltd. 33/2, A.B. Road, Pigdamber 453 446, Dist.- Indore (M.P.) 452 001 Email : mktgdom@alpalabs.in Email : hr@alpalabs.in Consequent to the aforesaid change in the composition of the Board, and in order to ensure continued compliance with Regulations 18, 19, 20 and 21 (as applicable) of the SEBI Listing Regulations, the Board also approved the reconstitution of the Audit Committee, the Nomination and Remuneration Committee, the Stakeholders Relationship Committee, and the Risk Management Committee (as applicable to the Company), The revised composition ofe ach of the aforesaid Committees, along with the designation of each member therein, is enclosed as Annexure B to this intimation. This is for your information and records. Thanking you. Yours faithfully, FOR ALPA LABORATORIES LIMITED Mabantirn Mahendra Singh Chawla Director DIN- 00362058 Alpa Laboratories Ltd. 3312, A.B. Road, Pigdamber 453 446, Dist.- Indore (M.P.) 452 001 Email : mktgdom@alpalabs.in Email : hr@alpalabs.in Annexure-A Disclosure under Part A of Schedule 11T of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Details of Mrs. Radhika Biyani (Independent Director) 2+ year work experi :—\\Lquing in ap rivate sector | Other Directorships | Number ofS hares held in Company Annexure-B RECONSTITUTED NOMINATION AND REMUNERATION COMMITTEE [0 TsAnKeTBARET T 1 C 2 RADHIKABIYANL ‘ [ 3 [SUNILKUMARVALECHA = ] RECONSTITUTED STAKEHOLDER COMMITTEE (SNo| S— C meoNme_ — 1 SUNIL KUMAR VALECHA - 2 | MAHENDRA SINGH CHAWLA |3 | RADHIKA BIYANI